Could MDMA help heal healthcare Heroes' hidden wounds?
NCT ID NCT05455996
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a therapy that uses MDMA (the active ingredient in ecstasy) can safely reduce post-traumatic stress symptoms in frontline healthcare workers and first responders. About 30 participants will receive the drug alongside talk therapy sessions. The goal is to ease distressing memories and improve mental health, not to cure PTSD permanently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADJUSTMENT DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
InnerMost, PBC
New York, New York, 10010, United States
-
Memoru
Boulder, Colorado, 80302, United States
-
The Pearl Institute
Waynesville, North Carolina, 28786, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a surgeon's mental health impact your surgery outcome?
- Zapping the brain with microcurrents may curb cravings — a trial puts it to the test
- Can a pressurized oxygen chamber keep brain benefits alive months later?
- A prescription app takes on PTSD: can digital therapy replace the couch?
- A targeted talk therapy aims to quiet the echoes of trauma
- Can a therapy that tackles both PTSD and everyday stress help those most at risk?